David A Rosa insider trades
Open-market stock purchases and sales by David A Rosa, CEO & President at NEUROONE MEDICAL TECHNOLOGIES Corp, from SEC Form 4 filings since May 6, 2013.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +216%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 28, 2026 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Bought (not open market) | — |
| Mar 31, 2026 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Sold (not open market) | $1.9K |
| Feb 18, 2026 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Sold (not open market) | $48.5K |
| Dec 31, 2025 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Bought (not open market) | $1.9K |
Companies traded
- NMTC NEUROONE MEDICAL TECHNOLOGIES Corp: 1 buy, last Aug 28, 2026
- BRTX BioRestorative Therapies, Inc: other filings, last Feb 14, 2025
- HCTI HealthCare Triangle, Inc: other filings, last Mar 12, 2024
- BTCY Biotricity Inc: 5 sales, last Mar 12, 2023
- OSOK NEUROONE MEDICAL TECHNOLOGIES Corp: other filings, last Jul 20, 2017
- SSH Sunshine Heart, Inc: other filings, last Aug 1, 2015